Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

Ling-Hui Dian,1,2,* Ying-Jie Hu,1,* Jia-Ye Lin,1 Jing-Ying Zhang,1 Yan Yan,1 Yi-Nuo Cui,1 Zhan-Bo Su,1 Wan-Liang Lu1 1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 2School of Pharmaceutical Sciences, Guangdong Medical University...

Full description

Bibliographic Details
Main Authors: Dian LH, Hu YJ, Lin JY, Zhang JY, Yan Y, Cui YN, Su ZB, Lu WL
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:International Journal of Nanomedicine
Subjects:
Paclitaxel
nanomicelles
oral
drug resistant breast cancer
mice.
Online Access:https://www.dovepress.com/fabrication-of-paclitaxel-hybrid-nanomicelles-to-treat-resistant-breas-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/fabrication-of-paclitaxel-hybrid-nanomicelles-to-treat-resistant-breas-peer-reviewed-article-IJN

Similar Items